Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (281-290 of 434) with videos related to

Pageof 44
Sort By:
Seminars in Arthritis and Rheumatism|February 21, 2026
Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitisMats Junek, Seungwon Choi, Stephanie Garner, et al.
Journal of Clinical Medicine|February 24, 2019
Genetic Variants in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Approach and Systematic ReviewKwang Seob Lee, Andreas Kronbichler, Daniel Fernando Pereira Vasconcelos, et al.
Frontiers in Immunology|October 5, 2020
Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated VasculitisGwen E Thompson, Lynn A Fussner, Amber M Hummel, et al.
The Journal of Rheumatology|February 3, 2019
Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and HealthNataliya Milman, Eilish McConville, Joanna C Robson, et al.
The American Journal of Medicine|December 28, 2005
Herpes zoster in immunocompromised patients: incidence, timing, and risk factorsPeter K Wung, Janet T Holbrook, Gary S Hoffman, et al.
Journal of Health Psychology|January 31, 2026
Development and initial validation of a brief measure of uncertainty in rheumatic diseaseCaleb Bolden, Lucy Finkelstein-Fox, April Jorge, et al.
RMD Open|April 30, 2024
Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitisJennifer Scott, Arthur White, Cathal Walsh, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
Pageof 44

Showing results (281-290 of 434) with videos related to

Sort By:
Pageof 44
Seminars in Arthritis and Rheumatism|February 21, 2026
Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitisMats Junek, Seungwon Choi, Stephanie Garner, et al.
Journal of Clinical Medicine|February 24, 2019
Genetic Variants in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Approach and Systematic ReviewKwang Seob Lee, Andreas Kronbichler, Daniel Fernando Pereira Vasconcelos, et al.
Frontiers in Immunology|October 5, 2020
Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated VasculitisGwen E Thompson, Lynn A Fussner, Amber M Hummel, et al.
The Journal of Rheumatology|February 3, 2019
Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and HealthNataliya Milman, Eilish McConville, Joanna C Robson, et al.
The American Journal of Medicine|December 28, 2005
Herpes zoster in immunocompromised patients: incidence, timing, and risk factorsPeter K Wung, Janet T Holbrook, Gary S Hoffman, et al.
Journal of Health Psychology|January 31, 2026
Development and initial validation of a brief measure of uncertainty in rheumatic diseaseCaleb Bolden, Lucy Finkelstein-Fox, April Jorge, et al.
RMD Open|April 30, 2024
Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitisJennifer Scott, Arthur White, Cathal Walsh, et al.
The Journal of Allergy and Clinical Immunology|December 23, 2018
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitisJonathan Steinfeld, Eric S Bradford, Judith Brown, et al.
The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
Pageof 44